SKIN TYPING FOR ASSESSMENT OF SKIN-CANCER RISK AND ACUTE RESPONSE TO UV-B AND ORAL METHOXSALEN PHOTOCHEMOTHERAPY

被引:81
作者
STERN, RS
MOMTAZ, K
机构
[1] MASSACHUSETTS GEN HOSP,DEPT DERMATOL,BOSTON,MA 02114
[2] CHARLES A DANA RES INST,DEPT DERMATOL,BOSTON,MA
[3] HARVARD UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA 02115
关键词
D O I
10.1001/archderm.120.7.869
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:869 / 873
页数:5
相关论文
共 10 条
  • [1] Fitzpatrick TB., 1975, J MED ESTHET, V2, P33
  • [2] PRELIMINARY-REPORT - MODIFIED GOECKERMAN THERAPY FOR HOSPITALIZED-PATIENTS - AMBULATORY DAY-CARE-CENTER AND IMPROVED QUANTITATIVE DOSIMETRY
    HARBER, LC
    ARMSTRONG, RB
    LEACH, EE
    WALTHER, RR
    FLEISS, JL
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 77 (01) : 162 - 166
  • [3] PLASMA-LEVELS OF 8-METHOXYPSORALEN DETERMINED BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY IN PSORIATIC PATIENTS INGESTING DRUG FROM 2 MANUFACTURERS
    LJUNGGREN, B
    CARTER, DM
    ALBERT, J
    REID, T
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (01) : 59 - 62
  • [4] MANTEL N, 1959, J NATL CANCER I, V22, P719
  • [5] ORAL METHOXSALEN PHOTOCHEMOTHERAPY FOR TREATMENT OF PSORIASIS - COOPERATIVE CLINICAL-TRIAL
    MELSKI, JW
    TANENBAUM, L
    PARRISH, JA
    FITZPATRICK, TB
    BLEICH, HL
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1977, 68 (06) : 328 - 335
  • [6] SKIN TYPE, MINIMAL ERYTHEMA DOSE (MED), AND SUNLIGHT ACCLIMATIZATION
    SAYRE, RM
    DESROCHERS, DL
    WILSON, CJ
    MARLOWE, E
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 5 (04) : 439 - 443
  • [7] Snedecor G.W., 1967, STAT METHODS, V6th, P593, DOI [DOI 10.1177/001316446902900247, 10.1177/001316446902900247]
  • [8] RISK OF CUTANEOUS CARCINOMA IN PATIENTS TREATED WITH ORAL METHOXSALEN PHOTOCHEMOTHERAPY FOR PSORIASIS
    STERN, RS
    THIBODEAU, LA
    KLEINERMAN, RA
    PARRISH, JA
    FITZPATRICK, TB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (15) : 809 - 813
  • [9] WILSON DD, 1981, J INVEST DERMATOL, V77, P434
  • [10] 1979, J AM ACAD DERMATOL, V1, P106